Advanced Cancer Therapeutics
Louisville · Founded 2007
About Advanced Cancer Therapeutics
Advanced Cancer Therapeutics, LLC engages in the discovery, development, manufacture, and commercialization of cancer therapeutics. It develops a pipeline of anti-cancer products, including MIF, a macrophage migration inhibitory factor; PU27, a synthetic oligonucleotide that is used as an anticancer compound; PFKFB3, a small molecule compound; CK37, a small molecule that inhibits cell proliferation, choline kinase enzymatic activity, and tumor growth; and a vaccine for human papilloma virus, which is caused for cervical cancer. The company was founded in 2007 and is based in Louisville, Kentucky.
Company Facts
- Founded: 2007
- Legal name: ADVANCED CANCER THERAPEUTICS, LLC
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $10.4M
- Funding stage: Early Stage Venture
- Last round: Grant (Oct 2012)
- Website: advancedcancertherapeutics.com
- Phone: +1 5025896391
Social Profiles
Canonical: https://fsome.com/organization/advanced-cancer-therapeutics-8323040 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.